State Medicaid programs must inform people affected by new work requirements with federally required notices, and most states are planning other types of outreach, including phone calls, public ads, and social media posts. This brief describes the federal outreach requirements and state plans, as well as the complexities and tight implementation timelines states face.
As healthcare continues to become more and more dependent on third-party vendor services, provider and technology entities must remain focused on the risks that their vendors present. The post “Here, There and Everywhere”: Vendor Risks in the Health Care Sector appeared first on MedCity News.
BioMarin Pharmaceutical’s acquisition of Amicus Therapeutics is a marriage of two rare disease biotech companies. Amicus’s two commercialized products, for the enzyme deficiencies Fabry disease and Pompe disease, are each projected to become blockbuster sellers. The post BioMarin’s Presence in Rare Enzyme Disorders Grows With $4.8B Amicus Therapeutics Acquisition appeared first on MedCity News.
Elisabeth Yoder’s son, Darragh, was 15 months old in August when he developed what at first looked to his parents like hand, foot, and mouth disease. The common viral infection generally clears up in less than a week, but Darragh’s condition worsened over several days. His skin turned bright red. Blisters gave way to skin…
[Sponsored] In an interview with MedCity News, Smarter Technologies CEO Jeremy Delinsky talked about the newly formed business Smarter Technologies and his ambition to automate hospitals’ revenue management capabilities with AI, which lags 2-5 years behind that of payers. The post How Smarter AI Strikes Back for Hospitals appeared first on MedCity News.
This tracker provides U.S. global health funding data by program area and country. It will be updated as new data become available.
That is the title of my article out today in The Evidence Base. Here is an excerpt: The Centers for Medicare and Medicaid Services (CMS) are now setting drug prices under the Medicare Drug Price Negotiation program. Unlike other health technology assessment (HTA) bodies worldwide, however, CMS will not consider quality-adjusted life years (QALYs) when setting drug…
Ollie Super has moved in and out of cancer treatment since she was diagnosed with neuroblastoma as a toddler in foster care. Now 8, the second grader is dealing with it again. Her cancer came back late last year. Ollie’s parents, who adopted her in 2020, tried to sign her up for a clinical trial…
Also: Nutex wants to speed up hospital development and a PE firm is buying Cross Country Healthcare.
Jacob Sweidan has seen his patients through the federal immigration raids of the 1990s, a sitting governor’s call to abolish birthright citizenship, and the highly publicized workplace crackdowns and family separation policies of President Donald Trump’s first term. But in his 40 years as a pediatrician in Southern California serving those too poor to afford…